Literature DB >> 6482173

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

H A Austin, L R Muenz, K M Joyce, T T Antonovych, J E Balow.   

Abstract

Prerandomization renal biopsy specimens were examined in 102 patients upon entry into prospective therapeutic trials of lupus nephritis in an attempt to identify early predictors of renal failure outcome. All 11 renal failures occurred among the 72 individuals with diffuse proliferative or membranoproliferative glomerulonephritis (DPGN/MPGN); thus, these patients were at modestly, but significantly, increased risk of endstage renal disease compared to those with focal proliferative, membranous, or mesangial glomerulonephritis. Considering the low incidence of endstage renal disease among patients with DPGN/MPGN, we sought to refine the prognostic information obtained from renal morphology by semiquantitative scoring of individual histologic features and by derivation of composite histologic scores specified by Activity (AI) and Chronicity (CI) Indices. Among the 72 patients with DPGN/MPGN, the composite AI was more strongly predictive of renal failure than were the individual active histologic features; cellular crescents and extensive fibrinoid necrosis yielded positive associations, while endocapillary proliferation, leucocytic exudation, and hyaline thrombi in glomeruli and interstitial inflammation by themselves did not emerge as useful prognostic indicators. However, chronicity items (glomerular sclerosis, fibrous crescents, tubular atrophy, and interstitial fibrosis) considered individually, as well as in the composite CI, were highly predictive of renal failure outcome. Particularly striking was the prognostic value of tubular atrophy; all 11 renal failures were among the 43 patients with tubular atrophy on prerandomization renal biopsy. While no single pathologic variable improved outcome predictions among those with tubular atrophy, examination for interactions among variables revealed that glomerular sclerosis and cellular crescents had a synergistic effect which augmented the prognostic information derived from analysis of tubular atrophy alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6482173     DOI: 10.1038/ki.1984.75

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  193 in total

1.  LUPUS NEPHRITIS-A CRITICAL ANALYSIS OF 17 PATIENTS.

Authors:  P K Prasher; P P Varma; K V Baliga; S S Uppal; J S Saini
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

3.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

4.  Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis.

Authors:  Zhu Chen; Guo-Sheng Wang; Gui-Hong Wang; Xiang-Pei Li
Journal:  Clin Rheumatol       Date:  2012-06-14       Impact factor: 2.980

Review 5.  Histopathology of lupus nephritis.

Authors:  Konstantinos Giannakakis; Tullio Faraggiana
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

Review 6.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

7.  Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier.

Authors:  Rahul D Pawar; Liliana Castrezana-Lopez; Ramanjaneyulu Allam; Onkar P Kulkarni; Stephan Segerer; Ewa Radomska; Tobias N Meyer; Catherine-Meyer Schwesinger; Nese Akis; Hermann-Josef Gröne; Hans-Joachim Anders
Journal:  Immunology       Date:  2008-10-24       Impact factor: 7.397

Review 8.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

9.  Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis.

Authors:  Qiu-Yu Li; Hai-Yun Li; Ge Fu; Feng Yu; Yi Wu; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

10.  Lupus nephritis in Egyptian children: a 16-year experience.

Authors:  Atef Elmougy; Amr Sarhan; Ayman Hammad; Ahmed El-Refaey; Mohammed Zedan; Riham Eid; Wafaa Laimon; Wafaa Limon; Ashraf Abd Elrahman; Fatma Elhussieni; Enas El-Sherbeny; Ashraf Bakr
Journal:  J Nephrol       Date:  2014-12-10       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.